MilliporeSigma to buy Natrix Separations with an eye on single use
MilliporeSigma has agreed to buy chromatography membrane supplier Natrix Separations to expand its vaccine and mAb production tech offering.
Archives for August 28, 2017
US FDA steps up enforcement against unscrupulous stem cell firms
The US FDA has warned a Florida-based clinic and seized vials of a smallpox vaccine in California used to create an unapproved product in a crackdown against "unscrupulous" stem cell firms.
Boehringer prepped to take on AbbVie and Amgen with US adalimumab biosimilar
The US FDA has approved its sixth biosimilar and second version of AbbVie’s best-selling monoclonal antibody Humira (adalimumab): Cyltezo, made by Boehringer-Ingelheim.